Ascendis Pharma (ASND) Tops Q1 EPS by 31c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. EXPE
3. FIS
4. ARM
5. BROS
6. QCOM
7. DDOG
8. EW
9. ZG
10. CPAY

Go back to Ascendis Pharma (ASND) Tops Q1 EPS by 31c

Ascendis Pharma A/S Reports First Quarter 2015 Financial Results

May 18, 2015 4:03 PM EDT

COPENHAGEN, Denmark, May 18, 2015 /PRNewswire/ -- Ascendis Pharma A/S (Nasdaq: ASND), a clinical stage biotechnology company that applies its innovative TransCon technology to address significant unmet medical needs, today announced financial results for the three months ended March 31, 2015.

Ascendis Pharma reported a cash balance of approximately 153.5 million at March 31, 2015. On February 2, 2015, Ascendis Pharma announced the closing of its initial public offering, with net proceeds of approximately $111.5 million (or approximately 98.3 million at such date) after deducting underwriting discounts, commissions and estimated offering expenses. 

"2015 promises to be an exciting year for Ascendis,"... More